Haruhiko Murata
FDA investigator · also recorded as A. Haruhiko Murata, Ee Horuhiko Murata
Appears on 2 documents from 2015 to 2018, mostly at sites in North Carolina. Most often cites testing and release for distribution (21 CFR 211.165).
- 2
- Documents on file
- 16.0
- Observations per 483
- 2015
- First seen
- 2018
- Most recent
What they cite most
From 19 observations- 21 CFR 211.165Testing and release for distribution4
- 21 CFR 211.192Production record review3
- 21 CFR 211.110Sampling and testing of in-process materials and drug products2
- 21 CFR 211.160General requirements2
- 21 CFR 211.42Design and construction features2
- 21 CFR 211.67Equipment cleaning and maintenance2
Activity by year
2015: 1, 2018: 1
Where
North Carolina 1 · Pennsylvania 1
Often inspects with
Is Haruhiko Murata coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2018-06-18 | 483 Seqirus IncJun 18, 2018 · Holly Springs, North Carolina | Holly Springs, North Carolina | — | |
| 2015-04-17 | 483 Merck Sharp & Dohme LLCApr 17, 2015 · West Point, Pennsylvania | West Point, Pennsylvania | 16 |
About this profile
What does Haruhiko Murata inspect?
Haruhiko Murata appears on 2 documents on file covering 2 sites, mostly in North Carolina.
What do they cite most often?
21 CFR 211.165 (testing and release for distribution), followed by 21 CFR 211.192 and 21 CFR 211.110.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Haruhiko Murata is dated Jun 18, 2018.